11-123642502-G-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001040151.2(SCN3B):c.389C>A(p.Ala130Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,461,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A130V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001040151.2 missense
Scores
Clinical Significance
Conservation
Publications
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndrome 7Inheritance: AD, Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001040151.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN3B | NM_001040151.2 | MANE Select | c.389C>A | p.Ala130Glu | missense | Exon 4 of 7 | NP_001035241.1 | ||
| SCN3B | NM_018400.4 | c.389C>A | p.Ala130Glu | missense | Exon 3 of 6 | NP_060870.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN3B | ENST00000299333.8 | TSL:1 MANE Select | c.389C>A | p.Ala130Glu | missense | Exon 4 of 7 | ENSP00000299333.3 | ||
| SCN3B | ENST00000392770.6 | TSL:1 | c.389C>A | p.Ala130Glu | missense | Exon 3 of 6 | ENSP00000376523.2 | ||
| SCN3B | ENST00000530277.5 | TSL:1 | c.389C>A | p.Ala130Glu | missense | Exon 4 of 6 | ENSP00000432785.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251424 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27535533)
Cardiovascular phenotype Uncertain:1
The p.A130E variant (also known as c.389C>A), located in coding exon 3 of the SCN3B gene, results from a C to A substitution at nucleotide position 389. The alanine at codon 130 is replaced by glutamic acid, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at